Bioactivity:

1. Pristimerin has anticancer activity , treatment with Pristimerin may be a potential strategy for the suppression of hypoxia-induced metastasis through the reversal of hypoxia-induced stem cell characteristics and EMT in cancer cells. 2. Pristimerin dow

CAS nr:

1258-84-0

Purity:

98%

Molecular Weight:

464,64

SMILES:

COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(C)=C(O)C(=O)C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1

Formula:

C30H40O4

Pathway:

Microbiology/Virology,NF-_b

Target:

Antibacterial,NF-_B